Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-10

Clinical Trial Update: The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects [NA]

View source ↗

Summary

This completed trial assesses whether GLP-1 contributes to improved glycemic control after Roux-en-Y gastric bypass in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Type 2 Diabetes | NA | Status: COMPLETED